Home » RANBAXY TO MARKET ETHYPHARM'S CARDIAC DRUG IN INDIA
RANBAXY TO MARKET ETHYPHARM'S CARDIAC DRUG IN INDIA
Ethypharm India, subsidiary of leading French multinational Drug Delivery Company Ethypharm SA, has signed out-licensing and supply contract agreements for a Fixed Dose Combination of Fenofibrate micronized 160 mg and Atorvastatin 10 mg with Ranbaxy, based out of India, which will be launched in the Indian market. BioSpectrum (http://www.biospectrumasia.com/content/180906IND1649.asp)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct